%0 Journal Article
%T Salvage carbon dioxide transoral laser microsurgery for laryngeal cancer after (chemo)radiotherapy: a European Laryngological Society consensus statement.
%A Piazza C
%A Paderno A
%A Sjogren EV
%A Bradley PJ
%A Eckel HE
%A Mäkitie A
%A Matar N
%A Paleri V
%A Peretti G
%A Puxeddu R
%A Quer M
%A Remacle M
%A Vander Poorten V
%A Vilaseca I
%A Simo R
%J Eur Arch Otorhinolaryngol
%V 278
%N 11
%D Nov 2021
%M 34226992
%F 3.236
%R 10.1007/s00405-021-06957-5
%X <B>OBJECTIVE: </B>To provide expert opinion and consensus on salvage carbon dioxide transoral laser microsurgery (CO2 TOLMS) for recurrent laryngeal squamous cell carcinoma (LSCC) after (chemo)radiotherapy [(C)RT].<BR><B>METHODS: </B>Expert members of the European Laryngological Society (ELS) Cancer and Dysplasia Committee were selected to create a dedicated panel on salvage CO2 TOLMS for LSCC. A series of statements regarding the critical aspects of decision-making were drafted, circulated, and modified or excluded in accordance with the Delphi process.<BR><B>RESULTS: </B>The expert panel reached full consensus on 19 statements through a total of three sequential evaluation rounds. These statements were focused on different aspects of salvage CO2 TOLMS, with particular attention on preoperative diagnostic work-up, treatment indications, postoperative management, complications, functional outcomes, and follow-up.<BR><B>CONCLUSIONS: </B>Management of recurrent LSCC after (C)RT is challenging and is based on the need to find a balance between oncologic and functional outcomes. Salvage CO2 TOLMS is a minimally invasive approach that can be applied to selected patients with strict and careful indications. Herein, a series of statements based on an ELS expert consensus aimed at guiding the main aspects of CO2 TOLMS for LSCC in the salvage setting is presented.